Navigation Links
Pharmasset Appoints Michael Rogers as Chief Development Officer
Date:11/1/2007

PRINCETON, N.J., Nov. 1 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS) appointed Michael D. Rogers, PhD, as its first Chief Development Officer, responsible for coordinating the global development activities for all of Pharmasset's drug programs. Dr. Rogers joins Pharmasset from GlaxoSmithKline, where he most recently served as Vice President, Division of Viral Diseases, responsible for antiviral discovery activities directed toward human immunodeficiency virus (HIV) and hepatitis C virus (HCV) indications.

Dr. Rogers has over 23 years of industry experience and has participated in all phases of antiviral and anti-infective drug development, including discovery, preclinical development, and phase 1, 2, 3 and 3b/4 clinical development programs. During his career, he has led multinational development teams from discovery to marketing and has a successful product development record, including Lexiva(R) and the approvals for Agenerase(R), Mepron(R) and Malarone(R).

"We are very pleased to have Mike join us," stated Schaefer Price, Pharmasset's President & CEO. "His experience and demonstrated leadership will be of great benefit to our product development teams."

Dr. Rogers received his doctorate in medical parasitology and a Master of Public Health degree in medical microbiology from the University of North Carolina. He completed a postdoctoral fellowship in clinical microbiology at St. Jude Children's Research Hospital in Memphis, Tennessee.

About Pharmasset

Pharmasset is a clinical stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections. Pharmasset's primary focus is on the development of oral therapeutics for th
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Sharon Ethanol appoints operations director
2. Kyron appoints former AMA chairman to board
3. Brady appoints GE efficiency expert as CTO
4. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
5. Johnson Controls appoints Roell to head EOC
6. SecurePipe appoints two senior execs
7. Milwaukees PointOne appoints new president and CEO
8. Third Wave appoints new chairman
9. Midwest Venture Summit disappoints; Cato grades Midwest governors
10. Sonic Foundry appoints Engineering Dean and Cometa CEO to Board of Directors
11. TeraMEDICA Appoints Prekop as New President
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... CAMBRIDGE, Mass. , May 5, 2015 /PRNewswire/ ... the closing of its initial public offering of ... offering price of $18.00 per share, including shares ... by the underwriters of their option to purchase ... public offering to Blueprint Medicines were approximately $168.6 million, ...
(Date:5/5/2015)... Hayden-McNeil is pleased to announce they ... for smaller courses. This program is specifically designed for ... , “I’m very excited about offering our publishing ... said Jeff McCarthy, Hayden-McNeil president. “By working with more ... to make education both more effective and affordable.” , ...
(Date:5/5/2015)... 5, 2015  Renova™ Therapeutics, a biopharmaceutical company ... and other chronic diseases, has engaged RAND Health ... to reflect the healthcare patterns of multiple advanced ... be used to characterize the impact the company,s ... those groups of patients and the overall health ...
(Date:5/5/2015)... 2015 Franz Inc ., the leading ... that its flagship product, AllegroGraph, has been named a Champion ... Update report. AllegroGraph is a high performance Semantic ... standards. Graph databases are skyrocketing in popularity and have grown ... recent DBMS ranking by DB-Engines. , “We are ...
Breaking Biology Technology:Blueprint Medicines Announces Closing of Initial Public Offering 2Hayden-McNeil Expands Publishing Program to Service Lower Enrollment Courses 2RAND Health Advisory Services modeling heart failure patient outcomes to inform potential impact of Renova Therapeutics lead product candidate 2RAND Health Advisory Services modeling heart failure patient outcomes to inform potential impact of Renova Therapeutics lead product candidate 3Bloor Research Positions AllegroGraph as a ‘Champion’ in Burgeoning Graph Database Market 2Bloor Research Positions AllegroGraph as a ‘Champion’ in Burgeoning Graph Database Market 3
... Johnson & Johnson (NYSE: JNJ ) ... of Omrix Biopharmaceuticals, Inc., a fully-integrated biopharmaceutical company that ... is expected to operate as a stand-alone entity reporting ... Johnson & Johnson , Caring for the world, ...
... SUNNYVALE, Calif., Dec. 30 Accuray Incorporated,(Nasdaq: ARAY ... today,that its president and chief executive officer, Euan S. Thomson, ... Healthcare Conference in San,Francisco, on Wednesday, January 14, 2009 at ... A live webcast of the presentation will be available ...
... and PHILADELPHIA, Pennsylvania,December 29 Rosetta Genomics, ... molecular diagnostics, announced,today the introduction of its ... now commercially available through Rosetta Genomics CLIA-certified,lab ... To order the test, physicians may contact ...
Cached Biology Technology:Accuray Incorporated's CEO to Speak at 27th Annual JP Morgan Healthcare Conference 2Rosetta Genomics Announces Commercial Availability of Its Third MicroRNA-Based Diagnostic Test: miRview(TM) meso 2Rosetta Genomics Announces Commercial Availability of Its Third MicroRNA-Based Diagnostic Test: miRview(TM) meso 3Rosetta Genomics Announces Commercial Availability of Its Third MicroRNA-Based Diagnostic Test: miRview(TM) meso 4Rosetta Genomics Announces Commercial Availability of Its Third MicroRNA-Based Diagnostic Test: miRview(TM) meso 5
(Date:3/31/2015)... 2015   Guidepoint , a leading global research ... Pain Management TRACKER, part of the Guidepoint TRACKER ... the medical device and therapeutics markets. The Post-Surgical Pain ... volumes, market share, and adoption rates across three major ... surgery. The Post-Surgical Pain Management TRACKER will ...
(Date:3/24/2015)... DUBLIN , Mar. 24, 2015 Research and ... addition of the "Global Iris Recognition Market 2015-2019" ... forecast the Global Iris Recognition market to grow at ... This report covers the present scenario and ... for the period 2015-2019. To calculate the market size, ...
(Date:3/24/2015)... GARDENS, Fla. , March 24, 2015 /PRNewswire/ ... identity management solutions, today announced that its U.are.U ... clothing accessory retailer Goorin Bros . to ... Crossmatch biometrics-based solution secures access to the POS ... the increased risk of data breaches. ...
Breaking Biology News(10 mins):Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2
... A major factor in the advance of heart disease is ... of scientists at Temple University School of Medicine,s (TUSM) Center ... Now, the researchers are one step closer to achieving that ... an unexpected place in heart cells mitochondria, tiny energy ...
... adding statistical nuance to our understanding of how modern ... model of Arctic temperature and how it relates to ... and lake sediments, Martin Tingley, a research associate in ... Huybers, Professor of Earth and Planetary Sciences, have shown ...
... and biomolecular engineering professor,s theories on crystal formation will ... Professor Peter Vekilov received a grant from NASA to ... form crystals. While researchers understand how crystals grow, they ... liquid to crystal. Vekilov discovered in 2004 that ...
Cached Biology News:Clues to heart disease in unexpected places, Temple researchers discover 2Clues to heart disease in unexpected places, Temple researchers discover 3New research helps place modern temperatures into a more complete statistical framework 2University of Houston engineering researcher's theories to be tested in space 2
... Slotted migration Chamber lid allows easy gel ... One-touch connectors for easy set up between power ... prevents current flow if the lid is removed ... and durability., Remote control can be ...
... ProFound Label Transfer Sulfo SBED Protein:Protein ... known as Label Transfer has rapidly gained ... protein interaction discovery. A growing number of ... Biotin Label Transfer Reagent to study a ...
... compact benchtop and stackable multi-function incubator. ... a large display screen to accurately ... circulation inside to evenly distribute temperature ... easily calibrated from the microprocessor controller. ...
... label transfer is fast emerging as a ... and confirmation. Until now, only amino groups ... label transfer reagents such as our Sulfo-SBED. ... Mts-Atf-LC-Biotin, are exciting additions to the protein ...
Biology Products: